Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201011810 Principal Investigator: Vij, Ravi
Title: Phase II Trial of High Dose Lenalidomide in Patients with Myelodysplastic Syndrome Refractory to Hypomethylating Agents
Phase: II Disease Site: Other Hematopoietic
Participating Site(s):
 
Main Campus
Map and Directions
South County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this research study is to see how patients with MDS that is not responsive to standard treatment respond to high dose lenalidomide followed by low dose lenalidomide.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)